America will soon impose "major tariffs" on pharmaceutical imports from other countries, Donald Trump has said. The president ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

The $1.7 trillion revenue prescription drug industry has a relatively robust immunity to tariffs. Last Wednesday, when U.S.

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an 8 ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Pharmaceuticals, among other products, will not be subject to the reciprocal tariffs, according to a White House fact sheet issued shortly after the US President’s address. Mumbai: India’s ...